STAT3 mediates bone marrow mesenchymal stem cell VEGF production

Meijing Wang, Wenjun Zhang, Paul Crisostomo, Troy Markel, Kirstan K. Meldrum, Xin Y. Fu, Daniel R. Meldrum

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

The mechanisms by which mesenchymal stem cells (MSCs) may protect native tissue are incompletely understood. Understanding the mechanisms by which these cells release factors such as vascular endothelial growth factor (VEGF), may lead to enhanced protection. We hypothesized that stress, in the form of hypoxia or TNF, activates MSCs to release VEGF by STAT3 and p38 MAPK dependent mechanisms. Mouse MSCs from wild type (WT) and STAT3 knockout mice (STAT3KO) were harvested and purified by a single-step method using adhesion. The release of VEGF was analyzed by using MSC conditioned media under hypoxia or TNF stimulation with or without p38 MAPK inhibition. Activation of STAT3 and p38 MAPK was determined by analysis of cell lysates. MSCs released VEGF under normoxia, which was associated with constitutive STAT3 activity. STAT3 deficiency resulted in decreased MSC production of VEGF. In response to hypoxia or TNF, MSCs produced more VEGF, which was correlated with hypoxia or TNF activated p38 MAPK and STAT3. The p38 MAPK inhibitor significantly decreased hypoxia-induced or TNF-stimulated VEGF production in WT. Additionally, STAT3 ablation neutralized hypoxia-induced MSC release of VEGF. No effect of p38 MAPK inhibitor alone was observed on MSC release of VEGF in WT. However, inhibition of p38 MAPK blocked release of VEGF in STAT3KO MSCs. MSCs are a potent source of VEGF, the production of which is mediated by STAT3 under normoxia partly; however, following hypoxia or TNF exposure, MSC release of VEGF is mediated by both STAT3 and p38 MAPK.

Original languageEnglish
Pages (from-to)1009-1015
Number of pages7
JournalJournal of Molecular and Cellular Cardiology
Volume42
Issue number6
DOIs
StatePublished - Jun 2007

Fingerprint

Mesenchymal Stromal Cells
Vascular Endothelial Growth Factor A
Bone Marrow
p38 Mitogen-Activated Protein Kinases
Knockout Mice
Conditioned Culture Medium
Hypoxia

Keywords

  • Growth substances
  • Hypoxia
  • Mesenchymal stromal cell
  • Signal transduction
  • STAT3

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Wang, M., Zhang, W., Crisostomo, P., Markel, T., Meldrum, K. K., Fu, X. Y., & Meldrum, D. R. (2007). STAT3 mediates bone marrow mesenchymal stem cell VEGF production. Journal of Molecular and Cellular Cardiology, 42(6), 1009-1015. https://doi.org/10.1016/j.yjmcc.2007.04.010

STAT3 mediates bone marrow mesenchymal stem cell VEGF production. / Wang, Meijing; Zhang, Wenjun; Crisostomo, Paul; Markel, Troy; Meldrum, Kirstan K.; Fu, Xin Y.; Meldrum, Daniel R.

In: Journal of Molecular and Cellular Cardiology, Vol. 42, No. 6, 06.2007, p. 1009-1015.

Research output: Contribution to journalArticle

Wang, M, Zhang, W, Crisostomo, P, Markel, T, Meldrum, KK, Fu, XY & Meldrum, DR 2007, 'STAT3 mediates bone marrow mesenchymal stem cell VEGF production', Journal of Molecular and Cellular Cardiology, vol. 42, no. 6, pp. 1009-1015. https://doi.org/10.1016/j.yjmcc.2007.04.010
Wang, Meijing ; Zhang, Wenjun ; Crisostomo, Paul ; Markel, Troy ; Meldrum, Kirstan K. ; Fu, Xin Y. ; Meldrum, Daniel R. / STAT3 mediates bone marrow mesenchymal stem cell VEGF production. In: Journal of Molecular and Cellular Cardiology. 2007 ; Vol. 42, No. 6. pp. 1009-1015.
@article{4740b5c7098a45c28c4ac0511b76d564,
title = "STAT3 mediates bone marrow mesenchymal stem cell VEGF production",
abstract = "The mechanisms by which mesenchymal stem cells (MSCs) may protect native tissue are incompletely understood. Understanding the mechanisms by which these cells release factors such as vascular endothelial growth factor (VEGF), may lead to enhanced protection. We hypothesized that stress, in the form of hypoxia or TNF, activates MSCs to release VEGF by STAT3 and p38 MAPK dependent mechanisms. Mouse MSCs from wild type (WT) and STAT3 knockout mice (STAT3KO) were harvested and purified by a single-step method using adhesion. The release of VEGF was analyzed by using MSC conditioned media under hypoxia or TNF stimulation with or without p38 MAPK inhibition. Activation of STAT3 and p38 MAPK was determined by analysis of cell lysates. MSCs released VEGF under normoxia, which was associated with constitutive STAT3 activity. STAT3 deficiency resulted in decreased MSC production of VEGF. In response to hypoxia or TNF, MSCs produced more VEGF, which was correlated with hypoxia or TNF activated p38 MAPK and STAT3. The p38 MAPK inhibitor significantly decreased hypoxia-induced or TNF-stimulated VEGF production in WT. Additionally, STAT3 ablation neutralized hypoxia-induced MSC release of VEGF. No effect of p38 MAPK inhibitor alone was observed on MSC release of VEGF in WT. However, inhibition of p38 MAPK blocked release of VEGF in STAT3KO MSCs. MSCs are a potent source of VEGF, the production of which is mediated by STAT3 under normoxia partly; however, following hypoxia or TNF exposure, MSC release of VEGF is mediated by both STAT3 and p38 MAPK.",
keywords = "Growth substances, Hypoxia, Mesenchymal stromal cell, Signal transduction, STAT3",
author = "Meijing Wang and Wenjun Zhang and Paul Crisostomo and Troy Markel and Meldrum, {Kirstan K.} and Fu, {Xin Y.} and Meldrum, {Daniel R.}",
year = "2007",
month = "6",
doi = "10.1016/j.yjmcc.2007.04.010",
language = "English",
volume = "42",
pages = "1009--1015",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - STAT3 mediates bone marrow mesenchymal stem cell VEGF production

AU - Wang, Meijing

AU - Zhang, Wenjun

AU - Crisostomo, Paul

AU - Markel, Troy

AU - Meldrum, Kirstan K.

AU - Fu, Xin Y.

AU - Meldrum, Daniel R.

PY - 2007/6

Y1 - 2007/6

N2 - The mechanisms by which mesenchymal stem cells (MSCs) may protect native tissue are incompletely understood. Understanding the mechanisms by which these cells release factors such as vascular endothelial growth factor (VEGF), may lead to enhanced protection. We hypothesized that stress, in the form of hypoxia or TNF, activates MSCs to release VEGF by STAT3 and p38 MAPK dependent mechanisms. Mouse MSCs from wild type (WT) and STAT3 knockout mice (STAT3KO) were harvested and purified by a single-step method using adhesion. The release of VEGF was analyzed by using MSC conditioned media under hypoxia or TNF stimulation with or without p38 MAPK inhibition. Activation of STAT3 and p38 MAPK was determined by analysis of cell lysates. MSCs released VEGF under normoxia, which was associated with constitutive STAT3 activity. STAT3 deficiency resulted in decreased MSC production of VEGF. In response to hypoxia or TNF, MSCs produced more VEGF, which was correlated with hypoxia or TNF activated p38 MAPK and STAT3. The p38 MAPK inhibitor significantly decreased hypoxia-induced or TNF-stimulated VEGF production in WT. Additionally, STAT3 ablation neutralized hypoxia-induced MSC release of VEGF. No effect of p38 MAPK inhibitor alone was observed on MSC release of VEGF in WT. However, inhibition of p38 MAPK blocked release of VEGF in STAT3KO MSCs. MSCs are a potent source of VEGF, the production of which is mediated by STAT3 under normoxia partly; however, following hypoxia or TNF exposure, MSC release of VEGF is mediated by both STAT3 and p38 MAPK.

AB - The mechanisms by which mesenchymal stem cells (MSCs) may protect native tissue are incompletely understood. Understanding the mechanisms by which these cells release factors such as vascular endothelial growth factor (VEGF), may lead to enhanced protection. We hypothesized that stress, in the form of hypoxia or TNF, activates MSCs to release VEGF by STAT3 and p38 MAPK dependent mechanisms. Mouse MSCs from wild type (WT) and STAT3 knockout mice (STAT3KO) were harvested and purified by a single-step method using adhesion. The release of VEGF was analyzed by using MSC conditioned media under hypoxia or TNF stimulation with or without p38 MAPK inhibition. Activation of STAT3 and p38 MAPK was determined by analysis of cell lysates. MSCs released VEGF under normoxia, which was associated with constitutive STAT3 activity. STAT3 deficiency resulted in decreased MSC production of VEGF. In response to hypoxia or TNF, MSCs produced more VEGF, which was correlated with hypoxia or TNF activated p38 MAPK and STAT3. The p38 MAPK inhibitor significantly decreased hypoxia-induced or TNF-stimulated VEGF production in WT. Additionally, STAT3 ablation neutralized hypoxia-induced MSC release of VEGF. No effect of p38 MAPK inhibitor alone was observed on MSC release of VEGF in WT. However, inhibition of p38 MAPK blocked release of VEGF in STAT3KO MSCs. MSCs are a potent source of VEGF, the production of which is mediated by STAT3 under normoxia partly; however, following hypoxia or TNF exposure, MSC release of VEGF is mediated by both STAT3 and p38 MAPK.

KW - Growth substances

KW - Hypoxia

KW - Mesenchymal stromal cell

KW - Signal transduction

KW - STAT3

UR - http://www.scopus.com/inward/record.url?scp=34249722245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249722245&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2007.04.010

DO - 10.1016/j.yjmcc.2007.04.010

M3 - Article

VL - 42

SP - 1009

EP - 1015

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 6

ER -